ABIRANAT TABLETS 250MG USP
Product details
Registration number: SIN15833P
Classification: Prescription Only
Active ingredients: Abiraterone Acetate
Strength: 250 mg
Dosage form: TABLET
Route: ORAL
Registrant: NATCO PHARMA ASIA PTE. LTD.
ATC code: L02BX03
HSA approval date: 18 October 2019
Manufacturer(s):
- Natco Pharma (Pharma - Division) Limited (Unit V)
- Natco Pharma (Pharma - Division) Limited (Unit XII)
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for ABIRANAT TABLETS 250MG USP?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15833P
Classification: Prescription Only
What active ingredients and strength are recorded for ABIRANAT TABLETS 250MG USP?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Abiraterone Acetate
Strength: 250 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ABIRANAT TABLETS 250MG USP?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: ORAL
Who is the recorded registrant for ABIRANAT TABLETS 250MG USP?
According to the HSA dataset updated 7 August 2026:
Registrant: NATCO PHARMA ASIA PTE. LTD.
Which manufacturers and countries are listed for ABIRANAT TABLETS 250MG USP?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Natco Pharma (Pharma - Division) Limited (Unit V)
- Natco Pharma (Pharma - Division) Limited (Unit XII)
Manufacturing country/countries: INDIA
Where can I look up ABIRANAT TABLETS 250MG USP in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15833P or the exact product name ABIRANAT TABLETS 250MG USP. The general register link does not preselect this product.
What are the source dates for this ABIRANAT TABLETS 250MG USP record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ABIRANAT TABLETS 250MG USP record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15833P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)